{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:07:28Z","timestamp":1774080448235,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY24H160026"],"award-info":[{"award-number":["LY24H160026"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10072-026-08848-1","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T01:59:54Z","timestamp":1770429594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic mechanisms of Parkinson's disease and potential epigenetic-based therapeutics"],"prefix":"10.1007","volume":"47","author":[{"given":"Mengyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-8179","authenticated-orcid":false,"given":"Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuezhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"8848_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00455","author":"N Gigu\u00e8re","year":"2018","unstructured":"Gigu\u00e8re N, Burke Nanni S, Trudeau L-E (2018) On cell loss and selective vulnerability of neuronal populations in Parkinson\u2019s disease. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2018.00455","journal-title":"Front Neurol"},{"issue":"4","key":"8848_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.tjnut.2025.01.028","volume":"155","author":"F Zhang","year":"2025","unstructured":"Zhang F et al (2025) Epidemiologic risk and prevention and interventions in Parkinson disease: from a nutrition-based perspective. J Nutr 155(4):1019\u20131030","journal-title":"J Nutr"},{"issue":"6","key":"8848_CR3","doi-asserted-by":"publisher","first-page":"a009282","DOI":"10.1101\/cshperspect.a009282","volume":"2","author":"P Mazzoni","year":"2012","unstructured":"Mazzoni P, Shabbott B, Cortes JC (2012) Motor control abnormalities in Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2(6):a009282\u2013a009282","journal-title":"Cold Spring Harb Perspect Med"},{"key":"8848_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.603854","volume":"12","author":"L Cui","year":"2020","unstructured":"Cui L et al (2020) Prevalence of Alzheimer\u2019s disease and Parkinson\u2019s disease in China: an updated systematical analysis. Front Aging Neurosci 12:603854","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"8848_CR5","doi-asserted-by":"publisher","first-page":"A160","DOI":"10.1289\/ehp.114-a160","volume":"114","author":"B Weinhold","year":"2006","unstructured":"Weinhold B (2006) Epigenetics: the science of change. Environ Health Perspect 114(3):A160","journal-title":"Environ Health Perspect"},{"issue":"8","key":"8848_CR6","doi-asserted-by":"publisher","first-page":"2388S","DOI":"10.1093\/jn\/132.8.2388S","volume":"132","author":"J-P Issa","year":"2002","unstructured":"Issa J-P (2002) Epigenetic variation and human disease. J Nutr 132(8):2388S-2392S","journal-title":"J Nutr"},{"issue":"20","key":"8848_CR7","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1212\/WNL.0000000000000440","volume":"82","author":"CJ Klein","year":"2014","unstructured":"Klein CJ, Benarroch EE (2014) Epigenetic regulation. Neurology 82(20):1833\u20131840","journal-title":"Neurology"},{"issue":"6","key":"8848_CR8","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1007\/s12035-021-02298-w","volume":"58","author":"HQ Zhang","year":"2021","unstructured":"Zhang HQ et al (2021) DNA methyltransferase 1 is dysregulated in Parkinson\u2019s disease via mediation of miR-17. Mol Neurobiol 58(6):2620\u20132633","journal-title":"Mol Neurobiol"},{"issue":"5321","key":"8848_CR9","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH et al (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"key":"8848_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/epigenomes7010005","author":"EY Fedotova","year":"2023","unstructured":"Fedotova EY et al (2023) SNCA gene methylation in Parkinson\u2019s disease and multiple system atrophy. Epigenomes. https:\/\/doi.org\/10.3390\/epigenomes7010005","journal-title":"Epigenomes"},{"issue":"11","key":"8848_CR11","doi-asserted-by":"publisher","first-page":"e15522","DOI":"10.1371\/journal.pone.0015522","volume":"5","author":"MB Feany","year":"2010","unstructured":"Feany MB et al (2010) CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of parkinson\u2019s disease. PLoS ONE 5(11):e15522","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"8848_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2013.11.033","volume":"337","author":"S-X Ai","year":"2014","unstructured":"Ai S-X et al (2014) Hypomethylation of SNCA in blood of patients with sporadic Parkinson\u2019s disease. J Neurol Sci 337(1\u20132):123\u2013128","journal-title":"J Neurol Sci"},{"issue":"10","key":"8848_CR13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4161\/epi.25865","volume":"8","author":"E Masliah","year":"2014","unstructured":"Masliah E et al (2014) Distinctive patterns of DNA methylation associated with Parkinson disease. Epigenetics 8(10):1030\u20131038","journal-title":"Epigenetics"},{"issue":"13","key":"8848_CR14","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/mds.26319","volume":"30","author":"I Schmitt","year":"2015","unstructured":"Schmitt I et al (2015) L-dopa increases \u03b1-synuclein DNA methylation in Parkinson\u2019s disease patients in vivo and in vitro. Mov Disord 30(13):1794\u20131801","journal-title":"Mov Disord"},{"issue":"3","key":"8848_CR15","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3390\/ijms24032687","volume":"24","author":"AR Smith","year":"2023","unstructured":"Smith AR et al (2023) DNA methylation of alpha-synuclein intron 1 Is significantly decreased in the frontal cortex of parkinson\u2019s individuals with GBA1 mutations. Int J Mol Sci 24(3):2687","journal-title":"Int J Mol Sci"},{"key":"8848_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/life12040502","author":"O Kaut","year":"2022","unstructured":"Kaut O et al (2022) Epigenome-wide analysis of DNA methylation in Parkinson\u2019s disease cortex. Life (Basel). https:\/\/doi.org\/10.3390\/life12040502","journal-title":"Life (Basel)"},{"issue":"13","key":"8848_CR17","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/mds.25784","volume":"29","author":"KG Coupland","year":"2014","unstructured":"Coupland KG et al (2014) DNA methylation of the MAPT gene in Parkinson\u2019s disease cohorts and modulation by vitamin E in vitro. Mov Disord 29(13):1606\u20131614","journal-title":"Mov Disord"},{"key":"8848_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-016-0052-6","volume":"5","author":"Y Tan","year":"2016","unstructured":"Tan Y et al (2016) Methylation status of DJ-1 in leukocyte DNA of Parkinson\u2019s disease patients. Transl Neurodegener 5:5","journal-title":"Transl Neurodegener"},{"issue":"8","key":"8848_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134087","volume":"10","author":"X Su","year":"2015","unstructured":"Su X et al (2015) PGC-1alpha promoter methylation in Parkinson\u2019s disease. PLoS ONE 10(8):e0134087","journal-title":"PLoS ONE"},{"issue":"4","key":"8848_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.parkreldis.2015.01.007","volume":"21","author":"S Searles Nielsen","year":"2015","unstructured":"Searles Nielsen S et al (2015) Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders. Parkinsonism Relat Disord 21(4):355\u2013360","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"8848_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15065-7","volume":"11","author":"CL Vallerga","year":"2020","unstructured":"Vallerga CL et al (2020) Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson\u2019s disease. Nat Commun 11(1):1238","journal-title":"Nat Commun"},{"key":"8848_CR22","doi-asserted-by":"crossref","unstructured":"Kochmanski J, Bernstein AI (2024) Best practices for epigenome-wide DNA modification data collection and analysis. Rigor and Reproducibility in Genetics and Genomics. pp 261\u2013284","DOI":"10.1016\/B978-0-12-817218-6.00006-1"},{"issue":"2","key":"8848_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JPD-181549","volume":"9","author":"YH Chuang","year":"2019","unstructured":"Chuang YH et al (2019) Longitudinal epigenome-wide methylation study of cognitive decline and motor progression in Parkinson\u2019s disease. J Parkinsons Dis 9(2):389\u2013400","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"8848_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrg.2017.33","volume":"18","author":"X Wu","year":"2017","unstructured":"Wu X, Zhang Y (2017) TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet 18(9):517\u2013534","journal-title":"Nat Rev Genet"},{"issue":"1","key":"8848_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41531-017-0007-3","volume":"3","author":"R St\u00f6ger","year":"2017","unstructured":"St\u00f6ger R et al (2017) Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis 3(1):6","journal-title":"NPJ Parkinson's Dis"},{"key":"8848_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep26591","volume":"6","author":"L Li","year":"2016","unstructured":"Li L et al (2016) Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers. Sci Rep 6:26591","journal-title":"Sci Rep"},{"issue":"8","key":"8848_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/hmg\/ddaa022","volume":"29","author":"T-T Wu","year":"2020","unstructured":"Wu T-T et al (2020) TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson\u2019s disease. Hum Mol Genet 29(8):1239\u20131252","journal-title":"Hum Mol Genet"},{"key":"8848_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2018.12.005","volume":"96","author":"O Kaut","year":"2019","unstructured":"Kaut O et al (2019) 5-methylcytosine and 5-hydroxymethylcytosine in brains of patients with multiple system atrophy and patients with Parkinson\u2019s disease. J Chem Neuroanat 96:41\u201348","journal-title":"J Chem Neuroanat"},{"issue":"20","key":"8848_CR29","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1093\/hmg\/ddac122","volume":"31","author":"S Min","year":"2022","unstructured":"Min S et al (2022) Altered hydroxymethylome in the substantia nigra of Parkinson\u2019s disease. Hum Mol Genet 31(20):3494\u20133503","journal-title":"Hum Mol Genet"},{"key":"8848_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf147","author":"JY Wang","year":"2025","unstructured":"Wang JY et al (2025) Detection of early Parkinson\u2019s disease using 5-hydroxymethylcytosine episignatures in blood DNA. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afaf147","journal-title":"Age Ageing"},{"issue":"1","key":"8848_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2010.01.011","volume":"62","author":"KC Dietz","year":"2010","unstructured":"Dietz KC, Casaccia P (2010) HDAC inhibitors and neurodegeneration: at the edge between protection and damage. Pharmacol Res 62(1):11\u201317","journal-title":"Pharmacol Res"},{"key":"8848_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00450-7","author":"L Toker","year":"2021","unstructured":"Toker L et al (2021) Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-021-00450-7","journal-title":"Mol Neurodegener"},{"key":"8848_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2016.05.060","volume":"627","author":"KG Gebremedhin","year":"2016","unstructured":"Gebremedhin KG, Rademacher DJ (2016) Histone H3 acetylation in the postmortem Parkinson\u2019s disease primary motor cortex. Neurosci Lett 627:121\u2013125","journal-title":"Neurosci Lett"},{"issue":"11","key":"8848_CR34","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1007\/s12035-024-04115-6","volume":"61","author":"R Singh","year":"2024","unstructured":"Singh R et al (2024) HAT and HDAC: enzyme with contradictory action in neurodegenerative diseases. Mol Neurobiol 61(11):9110\u20139124","journal-title":"Mol Neurobiol"},{"key":"8848_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2017.12.037","volume":"666","author":"IF Harrison","year":"2018","unstructured":"Harrison IF, Smith AD, Dexter DT (2018) Pathological histone acetylation in Parkinson\u2019s disease: neuroprotection and inhibition of microglial activation through SIRT 2 inhibition. Neurosci Lett 666:48\u201357","journal-title":"Neurosci Lett"},{"issue":"4","key":"8848_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"A Barski","year":"2007","unstructured":"Barski A et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129(4):823\u2013837","journal-title":"Cell"},{"key":"8848_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.639602","volume":"12","author":"E Di Nisio","year":"2021","unstructured":"Di Nisio E et al (2021) The role of histone lysine methylation in the response of mammalian cells to ionizing radiation. Front Genet 12:639602","journal-title":"Front Genet"},{"key":"8848_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1123621","author":"H Song","year":"2023","unstructured":"Song H et al (2023) Epigenetic modification in Parkinson\u2019s disease. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2023.1123621","journal-title":"Front Cell Dev Biol"},{"key":"8848_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep36328","author":"N Sugeno","year":"2016","unstructured":"Sugeno N et al (2016) \u0391-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses. Sci Rep. https:\/\/doi.org\/10.1038\/srep36328","journal-title":"Sci Rep"},{"key":"8848_CR40","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012188","author":"S Guhathakurta","year":"2021","unstructured":"Guhathakurta S et al (2021) Targeted attenuation of elevated histone marks at SNCA alleviates \u03b1-synuclein in Parkinson\u2019s disease. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.202012188","journal-title":"EMBO Mol Med"},{"key":"8848_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuropharm.2013.10.002","volume":"80","author":"A Vogel-Ciernia","year":"2014","unstructured":"Vogel-Ciernia A, Wood MA (2014) Neuron-specific chromatin remodeling: a missing link in epigenetic mechanisms underlying synaptic plasticity, memory, and intellectual disability disorders. Neuropharmacology 80:18\u201327","journal-title":"Neuropharmacology"},{"issue":"15\u201316","key":"8848_CR42","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1101\/gad.326066.119","volume":"33","author":"AP Bracken","year":"2019","unstructured":"Bracken AP, Brien GL, Verrijzer CP (2019) Dangerous liaisons: interplay between SWI\/SNF, NuRD, and Polycomb in chromatin regulation and cancer. Genes Dev 33(15\u201316):936\u2013959","journal-title":"Genes Dev"},{"issue":"5","key":"8848_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/jnc.14969","volume":"154","author":"P Sanphui","year":"2020","unstructured":"Sanphui P, Kumar Das A, Biswas SC (2020) Forkhead box O3a requires BAF57, a subunit of chromatin remodeler SWI\/SNF complex for induction of p53 up-regulated modulator of apoptosis (Puma) in a model of Parkinson\u2019s disease. J Neurochem 154(5):547\u2013561","journal-title":"J Neurochem"},{"key":"8848_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J et al (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2018.00402","journal-title":"Front Endocrinol"},{"issue":"7","key":"8848_CR45","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.20070823","volume":"204","author":"A Schaefer","year":"2007","unstructured":"Schaefer A et al (2007) Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 204(7):1553\u20131558","journal-title":"J Exp Med"},{"key":"8848_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071698","author":"S Paul","year":"2020","unstructured":"Paul S et al (2020) Current status of microRNA-based therapeutic approaches in neurodegenerative disorders. Cells. https:\/\/doi.org\/10.3390\/cells9071698","journal-title":"Cells"},{"issue":"9","key":"8848_CR47","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","volume":"85","author":"Y Su","year":"2019","unstructured":"Su Y et al (2019) Microrna-26a\/death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson\u2019s disease. Biol Psychiatry 85(9):769\u2013781","journal-title":"Biol Psychiatry"},{"issue":"3","key":"8848_CR48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/1440-1681.13212","volume":"47","author":"R Wang","year":"2019","unstructured":"Wang R et al (2019) MiR-29c protects against inflammation and apoptosis in Parkinson\u2019s disease model in vivo and in vitro by targeting SP1. Clin Exp Pharmacol Physiol 47(3):372\u2013382","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"8848_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jcb.26170","volume":"119","author":"RF Dong","year":"2017","unstructured":"Dong RF et al (2017) The neuroprotective role of MiR-124-3p in a 6-hydroxydopamine-induced cell model of Parkinson\u2019s disease via the regulation of ANAX5. J Cell Biochem 119(1):269\u2013277","journal-title":"J Cell Biochem"},{"key":"8848_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2018.03.037","volume":"675","author":"L Geng","year":"2018","unstructured":"Geng L et al (2018) Mir-494-3p modulates the progression of in vitro and in vivo Parkinson\u2019s disease models by targeting SIRT3. Neurosci Lett 675:23\u201330","journal-title":"Neurosci Lett"},{"key":"8848_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2019.02.038","volume":"701","author":"Z Wang","year":"2019","unstructured":"Wang Z et al (2019) Mir-9-5p modulates the progression of Parkinson\u2019s disease by targeting SIRT1. Neurosci Lett 701:226\u2013233","journal-title":"Neurosci Lett"},{"key":"8848_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01586-w","author":"L-X Zhang","year":"2022","unstructured":"Zhang L-X et al (2022) The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p\/CARM1 axis. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-022-01586-w","journal-title":"Mol Cancer"},{"issue":"5","key":"8848_CR53","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/mds.28467","volume":"36","author":"S Ravanidis","year":"2021","unstructured":"Ravanidis S et al (2021) Differentially expressed circular RNAs in peripheral blood mononuclear cells of patients with Parkinson\u2019s disease. Mov Disord 36(5):1170\u20131179","journal-title":"Mov Disord"},{"key":"8848_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102430","author":"Q Cheng","year":"2022","unstructured":"Cheng Q et al (2022) CircSV2b participates in oxidative stress regulation through miR-5107-5p-Foxk1-Akt1 axis in Parkinson\u2019s disease. Redox Biol. https:\/\/doi.org\/10.1016\/j.redox.2022.102430","journal-title":"Redox Biol"},{"issue":"5","key":"8848_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/15476286.2020.1722450","volume":"17","author":"M Paschou","year":"2020","unstructured":"Paschou M et al (2020) Neuronal microRNAs modulate TREK two-pore domain K(+) channel expression and current density. RNA Biol 17(5):651\u2013662","journal-title":"RNA Biol"},{"issue":"3","key":"8848_CR56","doi-asserted-by":"publisher","first-page":"315","DOI":"10.17219\/acem\/154658","volume":"32","author":"Y-J Zhang","year":"2022","unstructured":"Zhang Y-J et al (2022) CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p\/STAT3\/NLRP3 signaling pathway in Parkinson\u2019s disease. Adv Clin Exp Med 32(3):315\u2013329","journal-title":"Adv Clin Exp Med"},{"issue":"9","key":"8848_CR57","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1080\/15548627.2023.2196889","volume":"19","author":"Y Zhou","year":"2023","unstructured":"Zhou Y et al (2023) Circeps15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy. Autophagy 19(9):2520\u20132537","journal-title":"Autophagy"},{"key":"8848_CR58","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12179","author":"W Wang","year":"2021","unstructured":"Wang W et al (2021) CircSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR-29c-3p-mediated AMPK\/mTOR pathway in Parkinson\u2019s disease. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12179","journal-title":"Mol Med Rep"},{"key":"8848_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04934-2","author":"Q Liu","year":"2022","unstructured":"Liu Q et al (2022) Circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p\/\u03b1-syn pathway in Parkinson\u2019s disease. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-022-04934-2","journal-title":"Cell Death Dis"},{"issue":"6","key":"8848_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tcb.2011.04.001","volume":"21","author":"O Wapinski","year":"2011","unstructured":"Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21(6):354\u2013361","journal-title":"Trends Cell Biol"},{"key":"8848_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.gdata.2014.11.009","volume":"3","author":"L Soreq","year":"2015","unstructured":"Soreq L et al (2015) Whole transcriptome RNA sequencing data from blood leukocytes derived from Parkinson\u2019s disease patients prior to and following deep brain stimulation treatment. Genomics Data 3:57\u201360","journal-title":"Genomics Data"},{"issue":"10","key":"8848_CR62","doi-asserted-by":"publisher","first-page":"11223","DOI":"10.1096\/fj.201900830R","volume":"33","author":"A Simchovitz","year":"2019","unstructured":"Simchovitz A et al (2019) NEAT1 is overexpressed in Parkinson\u2019s disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress. FASEB J 33(10):11223\u201311234","journal-title":"FASEB J"},{"issue":"8","key":"8848_CR63","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s11011-021-00835-z","volume":"36","author":"H Huang","year":"2021","unstructured":"Huang H, Zheng S, Lu M (2021) Downregulation of lncRNA MEG3 is involved in Parkinson\u2019s disease. Metab Brain Dis 36(8):2323\u20132328","journal-title":"Metab Brain Dis"},{"issue":"4","key":"8848_CR64","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.1002\/jcb.27769","volume":"120","author":"D Xia","year":"2018","unstructured":"Xia D, Sui R, Zhang Z (2018) Administration of resveratrol improved Parkinson\u2019s disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1\/miR-129\/SNCA signaling pathway. J Cell Biochem 120(4):4942\u20134951","journal-title":"J Cell Biochem"},{"issue":"7","key":"8848_CR65","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1007\/s11064-020-03035-w","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xia Q, Lin J (2020) LncRNA H19 attenuates apoptosis in MPTP-induced Parkinson\u2019s disease through regulating miR-585-3p\/PIK3R3. Neurochem Res 45(7):1700\u20131710","journal-title":"Neurochem Res"},{"issue":"2","key":"8848_CR66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10735-020-09931-3","volume":"52","author":"H Wang","year":"2021","unstructured":"Wang H et al (2021) LncRNA SNHG1 promotes neuronal injury in Parkinson\u2019s disease cell model by miR-181a-5p\/CXCL12 axis. J Mol Histol 52(2):153\u2013163","journal-title":"J Mol Histol"},{"key":"8848_CR67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainresbull.2020.02.003","volume":"157","author":"Y Fan","year":"2020","unstructured":"Fan Y et al (2020) LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson\u2019s disease via ablating microRNA-125b-5p. Brain Res Bull 157:119\u2013127","journal-title":"Brain Res Bull"},{"issue":"9","key":"8848_CR68","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1515\/hsz-2018-0431","volume":"400","author":"Q Lin","year":"2019","unstructured":"Lin Q et al (2019) LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson\u2019s disease through RAB3IP. Biol Chem 400(9):1217\u20131228","journal-title":"Biol Chem"},{"issue":"6","key":"8848_CR69","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s12640-021-00437-8","volume":"39","author":"C Wang","year":"2021","unstructured":"Wang C, Zhang H, Li J (2021) LncRNA JHDM1D-AS1 suppresses MPP + -induced neuronal injury in Parkinson\u2019s disease via miR-134-5p\/PIK3R3 axis. Neurotox Res 39(6):1771\u20131781","journal-title":"Neurotox Res"},{"key":"8848_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03105-5","author":"M-D Mu","year":"2020","unstructured":"Mu M-D et al (2020) Therapeutic effect of a histone demethylase inhibitor in Parkinson\u2019s disease. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-020-03105-5","journal-title":"Cell Death Dis"},{"issue":"3","key":"8848_CR71","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cns.12059","volume":"19","author":"Y Wang","year":"2013","unstructured":"Wang Y et al (2013) A DNA methyltransferase inhibitor, 5-Aza-2\u2032-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson\u2019s disease-related genes in dopaminergic neurons. CNS Neurosci Ther 19(3):183\u2013190","journal-title":"CNS Neurosci Ther"},{"key":"8848_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuroscience.2011.08.010","volume":"194","author":"SK Kidd","year":"2011","unstructured":"Kidd SK, Schneider JS (2011) Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease. Neuroscience 194:189\u2013194","journal-title":"Neuroscience"},{"issue":"41","key":"8848_CR73","doi-asserted-by":"publisher","first-page":"34246","DOI":"10.1074\/jbc.M112.367540","volume":"287","author":"L Yao","year":"2012","unstructured":"Yao L et al (2012) Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects. J Biol Chem 287(41):34246\u201334255","journal-title":"J Biol Chem"},{"issue":"17","key":"8848_CR74","doi-asserted-by":"publisher","first-page":"16852","DOI":"10.18632\/aging.103578","volume":"12","author":"X Yang","year":"2020","unstructured":"Yang X et al (2020) Spermidine inhibits neurodegeneration and delays aging via the PINK1-PDR1-dependent mitophagy pathway in C. elegans. Aging 12(17):16852\u201316866","journal-title":"Aging"},{"key":"8848_CR75","doi-asserted-by":"crossref","unstructured":"Gangisetty O, Murugan S (2016) Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy. The Benefits of Natural Products for Neurodegenerative Diseases. pp 1\u201325","DOI":"10.1007\/978-3-319-28383-8_1"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-08848-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-08848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:01:59Z","timestamp":1774076519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-08848-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["8848"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-08848-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a review and does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}],"article-number":"239"}}